Bookmark

Add to MyYahoo RSS

bladder cancer News

News on bladder cancer continually updated from thousands of sources around the net.

15 hrs ago | PhysOrg Weblog

New knowledge of genes driving bladder cancer points to targeted treatments

The story of cancer care seems so simple: find the mutated gene that causes cancer and turn it off or fix it. But rarely does a single gene cause cancer.

Comment?

Related Topix: Health, National Cancer Institute, Charitable Organizations, Genetics

Wed Sep 10, 2014

The Chronicle Herald

National shortage of bladder cancer drug BCG affects N.S. patients

Some bladder cancer patients in the province are seeing a change to their treatment plans because of a national shortage of a crucial drug used to treat the disease. BCG, short for Bacillus Calmette-Guerin strain tice, is in short supply due to some manufacturing problems encountered by Merck.

Comment?

Related Topix: Health, Medicine, Urology

Mon Sep 08, 2014

Brandon Sun

Shortage of bladder cancer drug could be tragic for patients, doctor says

Bladder Cancer Canada says it is deeply concerned about the shortage of a drug critical to treating the common malignancy, which will be diagnosed in about 8,000 Canadians this year. The shortage of the medication - called bacillus Calmette-Guerin, or BCG - has been caused by manufacturing problems at plants operated by two different pharmaceutical companies - Merck and Sanofi Pasteur.

Comment?

Related Topix: Health, Sanofi Pasteur

The Globe and Mail

Canadian shortage of vital bladder cancer drug prompts rationing

Canada is experiencing a serious shortage of an essential drug for the treatment of bladder cancer. The principal supplier of BCG for bladder cancer treatment is Merck Canada Inc., which sells it under the brand name OncoTICE.

1 comment

Related Topix: Cancer, Medicine, Health

Fri Sep 05, 2014

Hispanic Business

U.S. Grants Pacific Edge Patent for Melanoma Detection

Specifically, the test in development identifies aggressiveness in Stage III melanomas. to grant patent protection for the 'Prognosis Prediction for Melanoma' test, which is in the development stage.

Comment?

Related Topix: Health, Biology, Science, Urology, Medicine

Thu Sep 04, 2014

Seeking Alpha

Theralase's Q2 Earnings: Edging Up On Revenue By 40% Quarter Over Quarter

Theralase hopes to displace its current device with the next-generation TLC-2000 biofeedback laser therapeutic device that will be launched in Q4 2014 in Canada. The Phase I/II trials to treat bladder cancer in humans using their PDC technology are expected to commence in Q1 2015.

Comment?

Related Topix: Biofeedback, Medicine, Health, Marketing

Wed Sep 03, 2014

Scoop

US grants Pacific Edge patent for melanoma detection

The United States Patent Office has granted Pacific Edge patent protection for 'Prognosis Prediction for Melanoma'. The patent covers the technology being used to develop the melanoma prognostic test that will enable clinicians to distinguish aggressive and life threatening melanomas from those that are not as aggressive.

Comment?

Related Topix: Health

BioSpace

Takeda Responds To Judgment In Diabetes Drug Case

12-0064). The court has yet to rule on Takeda and Eli Lilly & Co.' s post-trial motion for a new trial, or alternatively, a significantly reduced punitive damage award.

Comment?

Related Topix: Medicine, Diabetes, Health, Healthcare Law, Law, Actos, Pioglitazone (generic), Heart Failure

Medical News

Pacific Edge signs agreement with SCPMG to evaluate Cxbladder User Program

Pacific Edge Ltd, a cancer diagnostics company, has signed an agreement with Southern California Permanente Medical Group to research its User Program to evaluate its bladder cancer technology Cxbladder within the clinical settings of Kaiser Permanente's health care network.

Comment?

Related Topix: Oceania, New Zealand, World News, Hershey, PA

Medical News Today

Testing for invisible blood in urine to diagnose bladder cancer

New research which finds that invisible blood in urine may be an early warning sign of bladder cancer is likely to shape guidelines for clinicians.

Comment?

Related Topix: Health

Mon Sep 01, 2014

BioMed Central

Chromosomal imbalances in human bladder urothelial carcinoma:...

The existence of two distinct groups of tumors with different clinical characteristic is a remarkable feature of transitional cell carcinomas of the bladder.

Comment?

Related Topix: 10-20, Health

Medical News Today

Results of 10-year study indicate no association between pioglitazone and bladder cancer

Takeda Pharmaceutical Company Limited have announced the completion of the post-marketing commitment and submissions of data from a 10-year epidemiology study to regulatory authorities including the United States Food and Drug Administration , the European Medicines Agency and the Japanese Ministry of Health, Labour, and Welfare / the Japanese ... (more)

Comment?

Related Topix: Actos, Pioglitazone (generic), Medicine, Health, Millennium Pharmaceuticals, Pharmaceuticals, Takeda Pharmaceutical Company, Marketing, Food and Drug Administration

Sun Aug 31, 2014

EurekAlert!

Invisible blood in urine may indicate bladder cancer

New research which finds that invisible blood in urine may be an early warning sign of bladder cancer is likely to shape guidelines for clinicians.

Comment?

Related Topix: Health

Sat Aug 30, 2014

BioMed Central

High expression of GEM and EDNRA is associated with metastasis and...

The standard treatment for non-metastatic muscle-invasive bladder cancer is radical cystectomy with lymphadenectomy.

Comment?

Related Topix: Health

Thu Aug 28, 2014

New Statesman

Why releasing untested ebola drugs was the right thing to do

Nurses wearing protective suits escort a man infected with the ebola virus to a hospital in Monrovia, Liberia, 25 August.

Comment?

Related Topix: Medicine, Nursing, Food and Drug Administration, Vaccinations, Health

MedicineNet

Cancer 101 Pictures Slideshow: A Visual Guide to Understanding Cancer

In the most basic terms, cancer refers to cells that grow out-of-control and invade other tissues.

Comment?

Related Topix: Medicine, Cancer, Health, Genetics, Liver Cancer, Sarcoma

The Otago Daily Times

Advance for Pacific Edge

The signing of an agreement with a Californian medical group is further confirmation Pacific Edge Ltd is ''moving forward'' in the United States, Craigs Investment Partners broker Peter McIntyre says.

Comment?

Related Topix: California Government, California, Health

Sys-Con Media

Takeda Announces Completion of the Post-Marketing Commitment to...

In the five-year interim analysis published in Diabetes Care , a statistically significant increased risk among patients who used pioglitazone for two or more years was observed.1 However, the 10-year final analysis did not show any statistically significant findings of increased risk of bladder cancer with long term use of pioglitazone.2 The data ... (more)

Comment?

Related Topix: Marketing, Actos, Pioglitazone (generic), Medicine, Food and Drug Administration, Health, Diabetes, Insulin (generic), Humulin, Novolin

Pharmaceutical Online

What You Missed From Regulatory Agencies Recently - August 18-28, 2014

NICE has published final draft guidance stating that Celgene's Revlimid for myelodysplastic syndromes will be available on the NHS in England.

Comment?

Related Topix: Marketing, Oncology, Medicine, E. Coli, Food and Drug Administration

Pendle Today

Women's bladder cancer scanner handed over

Burnley MP Gordon Birtwistle and his fund-raising team hand over the new i 1 210,000 scanner which can detect ladies bladder scanner to Mohan Pillai and Shahid Islam at the Urology Unit in Burnley General Hospital.

Comment?

Related Topix: Health, Urology, Medicine

•••
•••
•••
•••
•••
•••
•••
•••